Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of serum microRNAs as potential biomarkers in Pompe disease

12 Jun 2019

Abstract excerpt

OBJECTIVE: To analyze the microRNA profile in serum of patients with Adult Onset Pompe disease (AOPD). METHODS: We analyzed the expression of 185 microRNAs in serum of 15 AOPD patients and five controls using microRNA PCR Panels. The expression levels of microRNAs that were deregulated were further studied in 35 AOPD patients and 10 controls using Real-Time PCR. Additionally, the skeletal muscle expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycogen Storage Diseases and Myoclonus
Share to Lysosomal Storage Disorders Research
Share to Muscle Physiology and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31353854
DOI: 10.1002/acn3.50800

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of serum microRNAs as potential biomarkers in Pompe diseasePMID 31353854Read ↗

microRNAs as biomarkers in Pompe diseaseSemantic proximity Read ↗

Prominent Respiratory Involvement Featured in High-Risk Screening for Late-Onset Pompe Disease in ChinaSemantic proximity Read ↗

A Comprehensive Update on Late-Onset Pompe Disease.Semantic proximity Read ↗

The emerging phenotype of late-onset Pompe disease: A systematic literature review.Semantic proximity Read ↗

Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry.Semantic proximity Read ↗

Methods of diagnosis of patients with Pompe disease: Data from the Pompe RegistrySemantic proximity Read ↗

MicroRNA-Based Therapeutic Perspectives in Myotonic DystrophySemantic proximity Read ↗

High-risk screening for late-onset Pompe disease in China: An expanded multicenter study.Semantic proximity Read ↗

Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human PatientsSemantic proximity Read ↗

Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophiesSemantic proximity Read ↗

Serum Profiling Identifies Novel Muscle miRNA and Cardiomyopathy-Related miRNA Biomarkers in Golden Retriever Muscular Dystrophy Dogs and Duchenne Muscular Dystrophy PatientsSemantic proximity Read ↗

Pompe Disease: From Basic Science to TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.